Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost effectively than the traditional biotech model.
![](https://directorstalk.net/wp-content/uploads/2023/12/Poolbeg-Pharma-plc-300x300.png)
HOOKIPA Pharma advances HIV vaccine trial with full enrollment
HOOKIPA Pharma is advancing HIV treatment with its Phase 1b trial for HB-500. This innovative therapy aims to boost immune responses in individuals with HIV.